Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics

被引:3
作者
Oh, So Yeon [1 ]
Park, Kwonoh [1 ]
Koh, Su-Jin [2 ]
Kang, Jung Hun [3 ]
Chang, Myung Hee [4 ]
Lee, Kyung Hee [5 ]
机构
[1] Pusan Natl Univ, Dept Internal Med, Yangsan Hosp, Med Oncol & Hematol, Yangsan, South Korea
[2] Ulsan Univ, Ulsan Univ Hosp, Dept Hematol & Oncol, Coll Med, Ulsan, South Korea
[3] Gyeongsang Natl Univ, Dept Internal Med, Coll Med, Jinju, South Korea
[4] Natl Hlth Insurance Serv Ilsan Hosp, Dept Internal Med, Oncol & Hematol, Goyang, South Korea
[5] Yeungnam Univ, Dept Internal Med, Coll Med, Hematol & Oncol, Daegu, South Korea
关键词
Opioid Risk Tool; Opioid-Related Disorders; Narcotic-Related Disorders; Cancer Pain; PAIN SENSITIVITY; SUBSTANCE-ABUSE; ADDICTION; MISUSE; MULTICENTER; VALIDATION; PRESSURE;
D O I
10.3346/jkms.2022.37.e185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The risk of opioid-related aberrant behavior (OAB) in Korean cancer patients has not been previously evaluated. The purpose of this study is to investigate the Opioid Risk Tool (ORT) in Korean cancer patients receiving opioid treatment. Methods: Data were obtained from a multicenter, cross-sectional, nationwide observational study regarding breakthrough cancer pain. The study was conducted in 33 South Korean institutions from March 2016 to December 2017. Patients were eligible if they had cancer-related pain within the past 7 days, which was treated with strong opioids in the previous 7 days. Results: We analyzed ORT results of 946 patients. Only one patient in each sex (0.2%) was classified as high risk for OAB. Moderate risk was observed in 18 males (3.3%) and in three females (0.7%). Scores above 0 were primarily derived from positive responses for personal or familial history of alcohol abuse (in men), or depression (in women). In patients with an ORT score of 1 or higher (n = 132, 14%), the score primarily represented positive responses for personal history of depression (in females), personal or family history of alcohol abuse (in males), or 16-45 years age range. These patients had more severe worst and average pain intensity (proportion of numeric rating scale >= 4: 20.5% vs. 11.4%, P < 0.001) and used rescue analgesics more frequently than patients with ORT scores of 0. The proportion of moderateor high-risk patients according to ORT was lower in patients receiving low doses of long-acting opioids than in those receiving high doses (2.0% vs. 6.6%, P = 0.031). Moderate or high risk was more frequent when ORT was completed in an isolated room than in an open, busy place (2.7% vs. 0.6%, P = 0.089). Conclusions: The score of ORT was very low in cancer patients receiving strong opioids for analgesia. Higher pain intensity may associate with positive response to one or more ORT item.
引用
收藏
页数:11
相关论文
共 37 条
  • [1] Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients
    Adams, LL
    Gatchel, R
    Robinson, RC
    Polatin, P
    Gajraj, N
    Deschner, M
    Noe, C
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2004, 27 (05) : 440 - 459
  • [2] Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen
    Barclay, Joshua S.
    Owens, Justine E.
    Blackhall, Leslie J.
    [J]. SUPPORTIVE CARE IN CANCER, 2014, 22 (07) : 1883 - 1888
  • [3] Development and validation of the current opioid misuse measure
    Butler, Stephen F.
    Budman, Simon H.
    Fernandez, Kathrine C.
    Houle, Brian
    Benoit, Christine
    Katz, Nathaniel
    Jamison, Robert N.
    [J]. PAIN, 2007, 130 (1-2) : 144 - 156
  • [4] Addressing Opioid-Related Chemical Coping in Long-Term Opioid Therapy for Chronic Noncancer Pain: A Multicenter, Observational, Cross-Sectional Study
    Castaneda, Anyela Marcela
    Lee, Chang-Soon
    Kim, Yong-Chul
    Lee, Dasom
    Moon, Jee Youn
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (10)
  • [5] Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Nonmalignant Pain
    Cheatle, Martin D.
    Compton, Peggy A.
    Dhingra, Lara
    Wasser, Thomas E.
    O'Brien, Charles P.
    [J]. JOURNAL OF PAIN, 2019, 20 (07) : 842 - 851
  • [6] Choi Ahrum, 2019, [Journal of Korean Society of Health-System Pharmacists, 병원약사회지], V36, P476, DOI 10.32429/jkshp.2019.36.4.005
  • [7] Three major haplotypes of the β2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder
    Diatchenko, Luda
    Anderson, Amy D.
    Slade, Gary D.
    Fillingim, Roger B.
    Shabalina, Svetlana A.
    Higgins, Tomas J.
    Sama, Swetha
    Inna, Belfer
    Goldman, David
    Max, Mitchell B.
    Weir, Bruce S.
    Maixner, William
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (05) : 449 - 462
  • [8] Ducharme James, 2019, Mo Med, V116, P318
  • [9] NARCOTIC ADDICTION IN PATIENTS WITH CHRONIC PAIN
    EVANS, PJD
    [J]. ANAESTHESIA, 1981, 36 (06) : 597 - 602
  • [10] Genetic contributions to pain: a review of findings in humans
    Fillingim, R. B.
    Wallace, M. R.
    Herbstman, D. M.
    Ribeiro-Dasilva, M.
    Staud, R.
    [J]. ORAL DISEASES, 2008, 14 (08) : 673 - 682